PATENT CLAIM ANALYSIS

Application Number: 16282817
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "454000"]

Abstract:
Oral cannabinoid formulations, including an aqueous-based oral dronabinol solution, that are stable at room or refrigerated temperatures and may possess improved in vivo absorption profiles with faster onset and lower inter-subject variability.

Claim (Index 3):
The solution of  claim 1 , wherein the alcohol is at a concentration from about 15 to about 65% w/w.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 99.0
- Lexical Diversity: 1.06061
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15132896', '13222989', '13644283', '11299183', '10656304']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7842707652713592
- 35 USC 102 Novelty (BERT): 0.5260061023801804
- Combined Prediction Score: 0.7584442989822413
- Mean Citation Score: 265.72394
- Max Citation Score: 313.5166
- Similarity Product: 185.27286284165388

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test